drugset / Trial / NCT05951153
Tributyrin to Promote Gut Health Among Children Undergoing Hematopoietic Cell Transplantation
NaSingle-groupOpen-labelPrevention
Summary
To determine the safety and tolerability of tributyrin among children undergoing hematopoietic cell transplantation (HCT).
Timeline
- Start
- 2024-08-01
- Primary completion
- 2025-11
- Completion
- 2026-11
Outcome
Outcome not reported
Stopped: “PI withdrew study”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | tributyrin | Other / unclassified | 100 mg/kg | Other |